Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Protein target quantification decision tree.

Kim JW, You J.

Int J Proteomics. 2013;2013:701247. doi: 10.1155/2013/701247. Epub 2013 Jan 15.

PMID:
23401774
[PubMed]
Free PMC Article
2.

Targeted mass spectrometry approaches for protein biomarker verification.

Meng Z, Veenstra TD.

J Proteomics. 2011 Nov 18;74(12):2650-9. doi: 10.1016/j.jprot.2011.04.011. Epub 2011 Apr 21. Review.

PMID:
21540133
[PubMed - indexed for MEDLINE]
3.

Targeted proteomics strategy applied to biomarker evaluation.

Kim YJ, Gallien S, van Oostrum J, Domon B.

Proteomics Clin Appl. 2013 Dec;7(11-12):739-47. doi: 10.1002/prca.201300070. Epub 2013 Oct 31.

PMID:
24123942
[PubMed - indexed for MEDLINE]
4.

Mass spectrometry for translational proteomics: progress and clinical implications.

Baker ES, Liu T, Petyuk VA, Burnum-Johnson KE, Ibrahim YM, Anderson GA, Smith RD.

Genome Med. 2012 Aug 31;4(8):63. doi: 10.1186/gm364. eCollection 2012. Review.

PMID:
22943415
[PubMed]
Free PMC Article
5.

On the development of plasma protein biomarkers.

Surinova S, Schiess R, Hüttenhain R, Cerciello F, Wollscheid B, Aebersold R.

J Proteome Res. 2011 Jan 7;10(1):5-16. doi: 10.1021/pr1008515. Epub 2010 Dec 13. Review.

PMID:
21142170
[PubMed - indexed for MEDLINE]
6.

Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.

Thomas A, Lenglet S, Chaurand P, Deglon J, Mangin P, Mach F, Steffens S, Wolfender JL, Staub C.

Thromb Haemost. 2011 Jul;106(1):20-33. doi: 10.1160/TH10-12-0812. Epub 2011 May 26. Review.

PMID:
21614412
[PubMed - indexed for MEDLINE]
7.

High-resolution biomarker discovery: Moving from large-scale proteome profiling to quantitative validation of lead candidates.

Hewel JA, Emili A.

Proteomics Clin Appl. 2008 Oct;2(10-11):1422-34. doi: 10.1002/prca.200800030. Epub 2008 Aug 26.

PMID:
21136791
[PubMed]
8.

The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.

Amacher DE.

Toxicol Appl Pharmacol. 2010 May 15;245(1):134-42. doi: 10.1016/j.taap.2010.02.011. Epub 2010 Feb 26. Review.

PMID:
20219512
[PubMed - indexed for MEDLINE]
9.

Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.

Lee JW, Figeys D, Vasilescu J.

Adv Cancer Res. 2007;96:269-98. Review.

PMID:
17161683
[PubMed - indexed for MEDLINE]
10.

Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Metzger J, Luppa PB, Good DM, Mischak H.

Crit Rev Clin Lab Sci. 2009;46(3):129-52. doi: 10.1080/10408360902805261. Review.

PMID:
19404829
[PubMed - indexed for MEDLINE]
11.
12.

The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.

Boehmer JL, DeGrasse JA, McFarland MA, Tall EA, Shefcheck KJ, Ward JL, Bannerman DD.

Vet Immunol Immunopathol. 2010 Dec 15;138(4):252-66. doi: 10.1016/j.vetimm.2010.10.004. Epub 2010 Oct 14. Review.

PMID:
21067814
[PubMed - indexed for MEDLINE]
13.

Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers.

Boja ES, Fehniger TE, Baker MS, Marko-Varga G, Rodriguez H.

J Proteome Res. 2014 Nov 18. [Epub ahead of print]

PMID:
25171765
[PubMed - as supplied by publisher]
14.

The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.

Makawita S, Diamandis EP.

Clin Chem. 2010 Feb;56(2):212-22. doi: 10.1373/clinchem.2009.127019. Epub 2009 Dec 10. Review.

PMID:
20007861
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.

Ekegren T, Hanrieder J, Bergquist J.

J Mass Spectrom. 2008 May;43(5):559-71. doi: 10.1002/jms.1409. Review.

PMID:
18416436
[PubMed - indexed for MEDLINE]
16.

Target-Decoy with Mass Binning: a simple and effective validation method for shotgun proteomics using high resolution mass spectrometry.

Joo JW, Na S, Baek JH, Lee C, Paek E.

J Proteome Res. 2010 Feb 5;9(2):1150-6. doi: 10.1021/pr9006377.

PMID:
19908919
[PubMed - indexed for MEDLINE]
17.

Biomarker rediscovery in diagnostics.

Kiernan UA.

Expert Opin Med Diagn. 2008 Dec;2(12):1391-400. doi: 10.1517/17530050802566488. Epub 2008 Nov 13.

PMID:
23496785
[PubMed]
18.

Emerging salivary biomarkers by mass spectrometry.

Wang Q, Yu Q, Lin Q, Duan Y.

Clin Chim Acta. 2014 Sep 3;438C:214-221. doi: 10.1016/j.cca.2014.08.037. [Epub ahead of print] Review.

PMID:
25195008
[PubMed - as supplied by publisher]
19.

The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.

Mikami T, Aoki M, Kimura T.

Curr Mol Pharmacol. 2012 Jun;5(2):301-16. Review.

PMID:
22122469
[PubMed - indexed for MEDLINE]
20.

High-resolution serum proteomic features for ovarian cancer detection.

Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF 3rd, Veenstra TD.

Endocr Relat Cancer. 2004 Jun;11(2):163-78.

PMID:
15163296
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk